🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial objectives were to investigate the tolerability and pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02218684
Treatments Being Tested
Computed Tomography (CT) is widely used in abdominal imaging for a variety ...
Status
Completed
Location
MUMC+
Start Date
2018-12-13
Trial ID
NCT03735706
Treatments Being Tested
The purpose of this study is to reconstruct a 12-lead electrocardiogram (EC...
Status
Completed
Location
UPMC Presbyterian
Start Date
2007-11
Trial ID
NCT00890461
Treatments Being Tested
Safety, tolerability and efficacy of BI 655066 in male and female patients ...
Status
Completed
Location
1311.1.0007 Boehringer Ingelheim Investigational Site
Start Date
2012-04
Trial ID
NCT01577550
To observe the clinical efficacy and adverse reactions of capecitabine in t...
Status
Completed
Location
Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer
Start Date
2022-01-01
Trial ID
NCT06246461
Treatments Being Tested
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-19
Trial ID
NCT02298179
Treatments Being Tested
Patients with impaired renal function are at elevated risk for development ...
Status
Completed
Location
Herzzentrum der Universität zu Köln
Start Date
2012-03
Trial ID
NCT01562925
Treatments Being Tested
The study is being conducted to evaluate the tolerability, pharmacokinetics...
Status
Completed
Location
Guangdong Provincial People's Hospital
Start Date
2022-03-10
Trial ID
NCT05221008
Treatments Being Tested
To investigate the dose-response relationship of DE-104 ophthalmic solution...
Status
Completed
Location
Sall Research Medical Center
Start Date
2008-03
Trial ID
NCT00650338